which glp-1 is approved for weight loss Safety Check GLP-1R Agonists for Weight Loss
Description
95% CI, 0.9-0.96) and myocardial infarction (HR = 0.91
In 2009, the first compound demonstrating anti-obesity effects was reported, a dual agonist targeting both the GLP-1 receptor and the glucagon receptor [24]
View on metformin: antidiabetic and pleiotropic effects, pharmacokinetics, side effects, and sex-related differences
Constipation: In some cases, constipation may occur, though it is generally less common than other gastrointestinal issues
Then theres the issue of side effects , including nausea, vomiting, and occasional pancreatitis
Patients drop 5 to 10 pounds during their first month
